tk88 bet

Taisho wants larger stake in DHG Pharmaceutical

Japan’s Taisho Pharmaceutical Co Ltd has proposed increasing its ownership in DHG Pharmaceutical Joint Stock Company by 21.7 percent.
Taisho wants larger stake in DHG Pharmaceutical ảnh 1Workers process products at DHG Pharmaceutical Company.
(Photo: taichinhplus.vn)

Hanoi (VNS/VNA) - Japan’s Taisho Pharmaceutical CoLtd has proposed increasing its ownership in DHG Pharmaceutical Joint StockCompany by 21.7 percent.

According to DHG Pharmaceutical, the Japanese firm has madea public offer to purchase more than 28.35 million shares.

The offered price is120,000 VND (5.16 USD) per share,putting the value of the deal at an estimated 3.4 trillion VND (146.2 millionUSD). Taisho will use its available cash to carry out the deal.

Taisho currently owns more than 45.76 million shares in DHGPharmaceutical, equal to a nearly 35 percent stake.

If the deal is successfully executed, Taisho will raise itsownership in DHG Pharmaceutical to nearly 56.7 percent, or more than 74 millionshares.

DHG Pharmaceutical has more than 130.7 million shares listedon the Ho Chi Minh Stock Exchange with code DHG.

The firm’s shares edged up 0.3 percent to end Wednesday at 119,000VND per share.

The company’s share price has jumped 40 percent sinceFebruary 11 and nearly 62 percent since the beginning of the year.

Taisho first invested in DHG Pharmaceutical in May 2016 bypurchasing a 24.4 percent stake for 100 million USD.

The Japanese firm made two more purchases of DHGPharmaceutical shares in 2018 that increased its ownership, first to 24.9 percentand then to 35 percent.

In July 2018, the State Securities Commission (SSC) approvedDHG Pharmaceutical’s request to lift the foreign ownership bar from the 49 percentlimit.

The State Capital Investment Corporation (SCIC) – therepresentative of the Government that controls State capital in local companies– is the largest shareholder at DHG Pharmaceutical with a 43.3 percent stake.

DHG Pharmaceutical is the largest Vietnamese pharmaceuticalfirm by market capitalisation and revenue.

As of the end of trading on March 6, the market value of DHGPharmaceutical was more than 15.5 trillion VND.

In 2018, DHG Pharmaceutical reported nearly 3.9 trillion VNDin total revenue and 651.6 billion VND in post-tax profit.

Its full-year revenue fulfilled 97 percent of the target andwas 4 percent lower than the 2017 figure. Meanwhile, its post-tax profit roseslightly from the 2017 number of 642 billion VND.-VNS/VNA
VNA

See more

The official logo of resort airline Sun PhuQuoc Airways (Photo: Sun Group)

ꦿ Official logo of resort airline Sun PhuQuoc Airways announced

Sun PhuQuoc Airways was born as a perfect piece in Sun Group’s strategic vision to build a premium ecosystem of tourism, entertainment, real estate, and aviation. With a pioneering ambition, Sun PhuQuoc Airways is not just an airline, but a symbol of connection – bringing the world to Phu Quoc and taking Phu Quoc to the world.
High-end apartment projects in Gamuda Gardens Urban Area in Hanoi are developed by Malaysian real estate group Gamuda Land. (Photo: VNA)

♐ OECD Economic Surveys: Vietnam 2025 report released

The OECD Economic Surveys: Vietnam 2025 report focuses on analysing the country’s macroeconomic fundamentals, the impact of international integration on attracting foreign investment and trade, and the country’s prospects for developing a low-carbon economy.
Vietnamese lychees make sweet impression on UK consumers (Photo: VNA)

Vietnamese lychees win over UK consumers

The event, co-organised by the Vietnam Trade Office in the UK and TT Meridian, a local importer of Vietnamese fresh produce, aims to build a national lychee brand and encourage broader recognition of Vietnamese fruits in a competitive, high-end market.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|